Dual Targeting of HDM2 and PPM1D As a Novel Therapeutic Approach for Myelofibrosis

被引：0
|
作者：
Marcellino, Bridget K. [1 ]
Clementelli, Cara [2 ]
Beaumont, Kristin [3 ]
Schaniel, Christoph [2 ]
Lu, Min [4 ]
Chen, Karie [2 ]
Russel, Adena [2 ]
Mohammad, Ayman [2 ]
Nathan, Daniel I. [2 ]
Aronin, Jake [2 ]
Shih, Alan H. [2 ]
Sebra, Robert [3 ]
Hoffman, Ronald [2 ,5 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA
[4] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, Elmhurst, NY USA
[5] MPN Res Consortium, New York, NY USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170232
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Molecular Profiling of Grade III Invasive Ductal Breast Cancers Identifies PPM1D Amplification as a Therapeutic Target in Luminal and HER2 Tumours
    Natrajan, R.
    Rodriguez-Pinilla, S. M.
    Lambros, M. B. K.
    Tan, D. S. P.
    Marchio, C.
    Vatcheva, R.
    Rayter, S.
    Moreno-Bueno, G.
    Fulford, L. G.
    Mackay, A.
    Grigoriadis, A.
    Fenwick, K.
    Tamber, N.
    Hardisson, D.
    Tutt, A.
    Palacios, J.
    Buerger, H.
    Lord, C. J.
    Ashworth, A.
    Reis-Filho, J. S.
    LABORATORY INVESTIGATION, 2009, 89 : 59A - 59A
  • [42] CARF (collaborator of ARF) interacts with HDM2: Evidence for a novel regulatory feedback regulation of CARF-p53-HDM2-p21WAF1 pathway
    Hasan, M. Kamrul
    Yaguchi, Tomoko
    Harada, Jun Itadani
    Hirano, Takashi
    Wadhwa, Renu
    Kaul, Sunil C.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 32 (03) : 663 - 671
  • [43] Targeting ARG2 as a novel therapeutic approach for cancer
    Grzybowski, M. M.
    Peczkowicz-Szyszka, J.
    Wolska, P.
    Stanczak, P. S.
    Welzer, M.
    Nikolaev, E.
    Siwinska, A. M.
    Blaszczyk, R.
    Borek, B.
    Dziegielewski, M.
    Gzik, A.
    Nowicka, J.
    Brzezinska, J.
    Jedrzejczak, K.
    Chrzanowski, J.
    Golebiowski, A.
    Olczak, J.
    Dzwonek, K.
    Dobrzanski, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [44] The Pathophysiological Significance and Therapeutic Targeting of PPM1D-Mediated Signaling in Mantle Cell Lymphoma
    Kojima, Kensuke
    Maeda, Aya
    Nishida, Yuki
    Kimura, Shinya
    BLOOD, 2016, 128 (22)
  • [45] Targeting AML through apoptosis activation using Bcl-2/Mcl-1 or Bcl-2/Hdm2 inhibitor combination therapies
    Wang, Youzhen
    Qui, Shumei
    Sanghavi, Sneha
    Mulford, Lain
    Lysiak, Gaelle
    Chanrion, Maia
    Mistry, Prakash
    Pfaar, Ulrike
    Schoumacher, Marie
    Claperon, Audrey
    Kraus-Berthier, Laurence
    Banquet, Sebastien
    Derreal, Alix
    Fabre, Claire
    Maacke, Heiko
    Colland, Frederic
    Geneste, Olivier
    Morris, Erick
    Halilovic, Ensar
    CANCER RESEARCH, 2019, 79 (13)
  • [46] A novel regulation of VEGF expression by HIF-1a and STAT3 in HDM2 transfected prostate cancer cells
    Rathinavelu, Appu
    Narasimhan, Madhusudhanan
    Muthumani, Praneetha
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (08) : 1750 - 1757
  • [47] Molecular and Clinical Spectra of Protein Phosphatase, Mg2+/Mn2+-Dependent 1D (PPM1D)-Mutant Myeloid Neoplasms
    Aly, Mai M. M.
    Visconte, Valeria
    Gurnari, Carmelo
    Alagooz, Reem
    Durmaz, Arda
    Balasubramanian, Suresh Kumar
    Singh, Abhay Singh
    Patel, Bhumika J.
    Kewan, Tariq
    Bahaj, Waled
    Maciejewski, Jaroslaw P.
    BLOOD, 2022, 140 : 12298 - 12300
  • [48] Siremadlin, a Human Double Minute-2 (HDM2) Inhibitor, Added to Ruxolitinib after Suboptimal Response to Ruxolitinib Alone in Patients with Myelofibrosis: Results from Part 1 of the Phase 1/2 Adore Study
    Heidel, Florian H.
    Perkins, Andrew Charles
    Reiter, Andreas
    Crodel, Carl C.
    Riley, Caroline Hasselbalch
    Gomez-Casares, Maria Teresa
    Takacs, Istvan
    Becker, Heiko
    Lehmann, Thomas
    Vinogradova, Olga
    Burbury, Kate
    Vannucchi, Alessandro M.
    Gupta, Vikas
    Harrison, Claire
    Wondergem, Marielle
    Kiladjian, Jean-Jacques
    Cleary, Grace
    Zhang, Angela
    Mahuzier, Bruyere
    Kota, Jagannath
    Prahallad, Anirudh
    Ross, David M.
    BLOOD, 2022, 140
  • [49] A novel combination therapy approach for the treatment of acute myeloid leukemia: the multi-kinase inhibitor sorafenib and the HDM2 inhibitor nutlin-3
    Weisberg, Ellen
    Sattler, Martin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (11): : 1620 - 1621
  • [50] A Novel Therapeutic Approach for Targeting LKB1-mediated Lung Metastasis
    Wei ZHOU Diansheng ZHONG Xiuju LIU Department of Hematology and Oncology Winship Cancer Institute Emory University School of Medicine Atlanta GA
    中国肺癌杂志, 2009, (06) : 13 - 13
12345